Dowling & Yahnke LLC Johnson & Johnson Transaction History

Dowling & Yahnke LLC

$215 Million
Q3 2022

A detailed history of Dowling & Yahnke LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Dowling & Yahnke LLC holds 94,777 shares of JNJ stock, worth $13.8 Million. This represents 7.21% of its overall portfolio holdings.

Number of Shares

94,777

Previous 95,525 0.78%

Holding current value

$13.8 Million

Previous $17 Million 8.69%

% of portfolio

7.21%

Previous 0.8%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 02, 2022	SELL	$161.33 - $179.52 $120,674 - $134,280	-748 Reduced 0.78%	94,777 $15.5 Million
Q2 2022 Aug 10, 2022	BUY	$168.19 - $186.01 $314,683 - $348,024	1,871 Added 2.0%	95,525 $17 Million
Q1 2022 May 04, 2022	SELL	$158.14 - $179.59 $968,765 - $1.1 Million	-6,126 Reduced 6.14%	93,654 $16.6 Million
Q4 2021 Feb 10, 2022	SELL	$155.93 - $173.01 $724,606 - $803,977	-4,647 Reduced 4.45%	99,780 $17.1 Million
Q3 2021 Nov 12, 2021	SELL	$161.5 - $179.47 $173,451 - $192,750	-1,074 Reduced 1.02%	104,427 $16.9 Million
Q2 2021 Jul 21, 2021	BUY	$159.48 - $171.07 $47,365 - $50,807	297 Added 0.28%	105,501 $17.4 Million
Q1 2021 Apr 29, 2021	SELL	$153.07 - $170.48 $2,296 - $2,557	-15 Reduced 0.01%	105,204 $17.3 Million
Q4 2020 Jan 28, 2021	BUY	$137.11 - $157.38 $903,006 - $1.04 Million	6,586 Added 6.68%	105,219 $16.6 Million
Q3 2020 Oct 19, 2020	BUY	$140.38 - $153.83 $4,632 - $5,076	33 Added 0.03%	98,633 $14.7 Million
Q2 2020 Jul 31, 2020	BUY	$128.81 - $155.51 $247,959 - $299,356	1,925 Added 1.99%	98,600 $13.9 Million
Q1 2020 May 15, 2020	SELL	$111.14 - $153.99 $209,832 - $290,733	-1,888 Reduced 1.92%	96,675 $12.7 Million
Q4 2019 Jan 27, 2020	SELL	$127.5 - $146.44 $7,395 - $8,493	-58 Reduced 0.06%	98,563 $14.4 Million
Q3 2019 Oct 29, 2019	BUY	$126.95 - $142.14 $192,075 - $215,057	1,513 Added 1.56%	98,621 $12.8 Million
Q2 2019 Jul 22, 2019	BUY	$131.15 - $144.24 $38,033 - $41,829	290 Added 0.3%	97,108 $13.5 Million
Q1 2019 Apr 30, 2019	BUY	$125.72 - $139.79 $760,480 - $845,589	6,049 Added 6.66%	96,818 $13.5 Million
Q4 2018 Jan 24, 2019	BUY	$122.84 - $147.84 $233,273 - $280,748	1,899 Added 2.14%	90,769 $13.3 Million
Q3 2018 Oct 30, 2018	BUY	$121.58 - $142.88 $1.42 Million - $1.67 Million	11,715 Added 15.18%	88,870 $12.3 Million
Q2 2018 Jul 30, 2018	SELL	$119.4 - $131.76 $61,132 - $67,461	-512 Reduced 0.66%	77,155 $9.36 Million
Q1 2018 May 01, 2018	SELL	$125.1 - $148.14 $124,599 - $147,547	-996 Reduced 1.27%	77,667 $9.95 Million
Q4 2017 Feb 02, 2018	SELL	$131.22 - $143.62 $6,036 - $6,606	-46 Reduced 0.06%	78,663 $11 Million
Q3 2017 Nov 08, 2017	BUY	$129.47 - $135.38 $10.2 Million - $10.7 Million	78,709	78,709 $10.2 Million

Others Institutions Holding JNJ

# of Institutions

4,275

Shares Held

1.68B

Call Options Held

17.6M

Put Options Held

14.5M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $381B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dowling & Yahnke LLC, based on Form 13F filings with the SEC.

News

Stay updated on Dowling & Yahnke LLC with notifications on news.

Account

Dowling & Yahnke LLC Johnson & Johnson Transaction History